Company Update Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Zydus Lifesciences receives final approval from USFDA for Adapalene and Benzoyl Peroxide Topical Gel